Cedar Knolls, NJ, United States of America

Bojan Lalovic

This inventor holds 1 USPTO granted patent and 7 published patent applications, plus 1 CIPO patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bojan Lalovic: Innovator in Inflammatory Disease Treatment

Introduction

Bojan Lalovic is a notable inventor based in Cedar Knolls, NJ (US). He has made significant contributions to the field of medical treatments, particularly focusing on inflammatory diseases. His innovative work has led to the development of methods that target IL-23 related diseases.

Latest Patents

Bojan Lalovic holds a patent for "Methods of treating inflammatory diseases." This invention relates to methods for the treatment of IL-23 related diseases, specifically inflammatory conditions such as psoriasis, psoriatic arthritis, and axial spondyloarthritis. His approach utilizes anti-IL-23A antibodies to provide effective treatment options for patients suffering from these conditions. He has 1 patent to his name.

Career Highlights

Bojan is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role involves research and development aimed at improving therapeutic strategies for inflammatory diseases. His expertise and dedication have positioned him as a valuable asset in the medical research community.

Collaborations

Bojan has collaborated with several professionals in his field, including Matthias Arndt and Stella Aslanyan. These collaborations have fostered a productive environment for innovation and advancement in treatment methodologies.

Conclusion

Bojan Lalovic's contributions to the treatment of inflammatory diseases highlight his commitment to medical innovation. His work not only advances scientific understanding but also offers hope for improved patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…